Drug Shortage Report for SANDOZ TIMOLOL
Report ID | 64219 |
Drug Identification Number | 02166720 |
Brand name | SANDOZ TIMOLOL |
Common or Proper name | TIMOLOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5 ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-09-10 |
Estimated end date | 2018-11-02 |
Actual end date | 2018-11-02 |
Shortage status | Resolved |
Updated date | 2018-11-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-11-04 | French | Compare |
v3 | 2018-11-04 | English | Compare |
v2 | 2018-10-15 | French | Compare |
v1 | 2018-10-15 | English | Compare |
Showing 1 to 4 of 4